News in Numbers

 The median M&A deal size for 15 of the top MedTech companies was $895m from 2021- 2025, four times higher than the median deal size for the same companies between 2016-2020, as per GlobalData analysis.

Over 3 billion people live with neurological disorders, now making them the leading cause of ill health worldwide, according to the World Health Organization (WHO).

In Science Corporation’s BCI retinal implant trial, 84% of patients who had lost their sight to dry AMD could read letters, numbers and words using the company's BCI implant.

The intraocular lens market is projected to reach $5.6bn by 2034, up from $4.6bn in 2024, as per recent GlobalData analysis.

Data supporting Roche's Alzheimer's test approval by the FDA found that it could rule out Alzheimer’s disease pathology with a 97.9% negative predictive value (NPV).